Boston Scientific CorporationBSX
NYSE•Healthcare•Medical Devices
Understand cash generation quality and how management allocates capital.
Free cash flow was $171.00M in the latest quarter (51.7% decrease YoY). FCF margin is 0.8%. Shares outstanding increased by 0.5% year-over-year, indicating dilution (potentially from stock compensation or capital raises). Free cash flow is the lifeblood of a business — it funds dividends, buybacks, debt reduction, and reinvestment without relying on external capital.
Free cash flow, earnings quality, and capital allocation